| Literature DB >> 27195383 |
Travis G Maak1, James D Wylie.
Abstract
Medical device regulation is a controversial topic in both the United States and the European Union. Many physicians and innovators in the United States cite a restrictive US FDA regulatory process as the reason for earlier and more rapid clinical advances in Europe. The FDA approval process mandates that a device be proved efficacious compared with a control or be substantially equivalent to a predicate device, whereas the European Union approval process mandates that the device perform its intended function. Stringent, peer-reviewed safety data have not been reported. However, after recent high-profile device failures, political pressure in both the United States and the European Union has favored more restrictive approval processes. Substantial reforms of the European Union process within the next 5 to 10 years will result in a more stringent approach to device regulation, similar to that of the FDA. Changes in the FDA regulatory process have been suggested but are not imminent.Mesh:
Year: 2016 PMID: 27195383 DOI: 10.5435/JAAOS-D-15-00403
Source DB: PubMed Journal: J Am Acad Orthop Surg ISSN: 1067-151X Impact factor: 3.020